Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05326178
Other study ID # 20116_2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 12, 2021
Est. completion date May 2, 2022

Study information

Verified date June 2022
Source Ludwig-Maximilians - University of Munich
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the efficacy and acceptability of the website "ich bin alles" (https://www.ich-bin-alles.de/) to improve depression literacy (knowledge about depression, which aid the recognition, treatment or prevention of depression) in parents of healthy adolescents without a mental health condition. The investigators will examine whether the website improves depression literacy in parents of adolescents aged 12 to 18 years without a mental health condition. The investigators will also assess the acceptability of the website among the participants.


Description:

Few young people with major depressive disorder seek professional treatment in time. Concerns about social stigma, confidentiality, and limited knowledge about mental health conditions, such as depression, or mental health services are some of the main barriers to seek treatment. Increasing parents' knowledge about and attitude towards depression and mental health in childhood and adolescence is important to sensitize parents and increase their awareness towards depression and mental health in their children. These aspects might play a crucial role for parents to support their children's mental health, notice potential depressive symptoms in their children, react appropriately and take action if necessary. To address these issues and to contribute to knowledge gain in this target group, we developed an evidence-based website "ich bin alles" with two separate sub-websites for (1) adolescents (https://www.ich-bin-alles.de/) and (2) parents (…../eltern) to improve depression literacy in these groups. To improve depression literacy in parents, the website provides general information for parents about depression in childhood and adolescence (e.g., symptoms, causes, course and treatment of depression). Furthermore, the website provides information about strategies for parents on how to support their children if they are affected by depression and on appropriate prevention strategies; i.e., strategies for promoting mental health (e.g., providing a healthy environment, reducing stress, undertaking positive activities, positive parenting), which are meant to serve as an addition to professional treatments of depression or to promote mental health in adolescents. Target groups of the website are parents of adolescents aged 12 to 18 years with a history of depression, as well as parents of healthy adolescents aged 12 to 18 years. Easy access to information about depression would make early recognition of depression more likely and engage parents to help their children to seek help for depression. Since the website targets two different groups, the investigators will evaluate the website accordingly: Target group 1: Parents of adolescents with a major depressive disorder (acute or remitted) Target group 2: Parents of healthy adolescents (without a mental health condition) The current study will focus on target group 2. A study focusing on target group 1 can be found in a separately registered clinical trial on clinicaltrials.gov. The primary aim of this study is to evaluate the efficacy and acceptability of the website "ich bin alles" (https://www.ich-bin-alles.de/) to improve depression literacy in parents of healthy adolescents without a mental health condition.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date May 2, 2022
Est. primary completion date May 2, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - The absence of a current or remitted diagnosis of any psychiatric disorder in the participants' children is assessed using a semi-structured clinical interview: the "Kinder-DIPS". The Kinder-DIPS is a well-established German interview for the diagnosis of a wide range of axis I psychiatric disorders in children from ages six to 18. Exclusion Criteria: - Insufficient knowledge of German

Study Design


Related Conditions & MeSH terms


Intervention

Other:
General information about depression
Before starting the intervention, the participants are told that they will be shown parts of a website about depression. The participants are instructed to carefully attend to the website (e.g., to read the text precisely, to hear attentively to the podcasts and to view carefully the videos and images on the website). The time window spent for the reception of each part of the website are fixed. The participants will be shown parts of the website regarding general information about depression.

Locations

Country Name City State
Germany Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Munich, Munich, Germany Munich Bavaria

Sponsors (2)

Lead Sponsor Collaborator
Ludwig-Maximilians - University of Munich Prof. OTTO Beisheim Stiftung (Germany)

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Depression Literacy - Depression in children and adolescents as psychiatric disorder This self-designed questionnaire is a self-report inventory to assess knowledge of depression in children and adolescents (frequency and comorbidities, treatment, symptoms, causes and course of depression; 26 items), with higher scores indicating more knowledge of depression as psychiatric disorder. Participants will complete this self-designed questionnaire at pre-test, post-test and follow-up to determine change in knowledge of depression in children and adolescents. Pre-Test, Post-Test (within 2 hours), Follow-Up (Week 4)
Secondary Visual Aesthetics of Websites Inventory Short Version (VisAWI-S) The short version of the Visual Aesthetics of Websites Inventory (VisAWI-S) is self-report inventory to assess the evaluation of the website's design - especially the perceived visual aesthetics. Participants indicate their response to the four items (e.g., "The layout appears professionally designed") on a seven-point Likert scale (ranging from 1 "do not agree at all" to 7 "do fully agree"). Post-Test (within 2 hours)
Secondary Overall reception of the website The overall reception of the website as measured with a self-designed questionnaire Post-Test (within 2 hours)
See also
  Status Clinical Trial Phase
Completed NCT01316926 - Paxil CR Bioequivalence Study Brazil Phase 1
Recruiting NCT06187454 - Transcranial Direct Current Stimulation for Depression N/A
Completed NCT04469322 - Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression N/A
Recruiting NCT05768126 - Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine Phase 4
Completed NCT03219879 - Telephone-administered Relapse Prevention for Depression N/A
Recruiting NCT06038721 - Unified Protocol: Community Connections N/A
Completed NCT03043560 - Study to Treat Major Depressive Disorder With a New Medication Phase 2
Completed NCT04091139 - Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong Phase 2/Phase 3
Completed NCT00069459 - Seasonal Affective Depression (SAD) Study Phase 1
Recruiting NCT05503966 - Combining Antidepressants and Attention Bias Modification in Depression N/A
Recruiting NCT03001245 - Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents N/A
Completed NCT02939560 - TMS for Adults With Autism and Depression N/A
Completed NCT02452892 - Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD) N/A
Completed NCT02542891 - European Comparative Effectiveness Research on Internet-based Depression Treatment N/A
Completed NCT02306551 - Well Being And Resilience: Mechanisms of Transmission of Health and Risk
Withdrawn NCT02238730 - Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy N/A
Completed NCT02224508 - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks N/A
Completed NCT01407575 - Buprenorphine for Treatment Resistant Depression Phase 3
Completed NCT01597661 - Bupropion & Cardio Birth Defect (Slone) N/A
Completed NCT01093053 - Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations N/A